Condition
Anal HSIL
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Not Yet Recruiting2
Recruiting1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06949800Phase 2Not Yet Recruiting
CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
NCT07123558Not ApplicableNot Yet RecruitingPrimary
Anal Cancer Prevention in High-Risk Categories of Men Who Have Sex With Men
NCT06206564Phase 2Recruiting
Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
NCT05858021Unknown
COrSIcA: Disease Measurement
Showing all 4 trials